Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank-Reference-Cited by-同舟云学术

Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank

Published:2000-11 Issue:8 Volume:10 Page:727-739
ISSN:0960-314X
Container-title:Pharmacogenetics
language:en
Short-container-title:Pharmacogenetics

Author:

Fisher Michael B.,VandenBranden Mark,Findlay Karen,Burchell Brian,Thummel Kenneth E.,Hall Stephen D.,Wrighton Steven A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference47 articles.

1. The Monkey and Human Uridine Diphosphate-Glucuronosyltransferase UGT1A9, Expressed in Steroid Target Tissues, Are Estrogen-Conjugating Enzymes*

2. Review: first-pass metabolism by the gastrointestinal mucosa

3. Limitations of hepatocytes and liver homogenates in modelling in vivo formation of acyl glucuronide-derived drug–protein adducts

4. Cooperative ligand binding by bovine phenol sulfotransferase

5. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: A balanced polymorphism for regulation of bilirubin metabolism?

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic Characterization of Estradiol Glucuronidation by Liver Microsomes and Expressed UGT Enzymes: The Effects of Organic Solvents;European Journal of Drug Metabolism and Pharmacokinetics;2024-03-12

2. Intestinal organoids as an in vitro platform to characterize disposition, metabolism, and safety profile of small molecules;European Journal of Pharmaceutical Sciences;2023-09

3. PK-TK Considerations of Nasal, Pulmonary and Oral Routes of Administration;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

4. Characterization of Enzymes Involved in Nintedanib Metabolism in Humans;Drug Metabolism and Disposition;2023-03-16

5. Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia;Scientific Reports;2021-05-27